Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
872.4 INR | -3.02% | +0.01% | +34.37% |
23/05 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
22/05 | Strides Pharma Arm Gets US FDA's Approval for Generic Stomach Ulcer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.37% | 99Cr | |
+18.71% | 4.44TCr | |
+19.44% | 1.51TCr | |
+19.49% | 1.44TCr | |
+57.58% | 1.31TCr | |
-0.05% | 678.76Cr | |
-10.71% | 675.38Cr | |
-8.87% | 572.55Cr | |
+12.55% | 564.23Cr | |
+4.00% | 465.54Cr |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Arm Gets US FDA's Approval for Generic Drug for Hypocalcemia